Download presentation
Presentation is loading. Please wait.
Published byAusten Newton Modified over 9 years ago
1
Swiss Life Sciences Trend Analysis 2014
2
About Us The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. www.biotechgate.com www.biotechgate.com The Swiss Life Sciences Database is a part of the global Biotechgate and is brought to you in partnership with Swiss Biotech Association, Biotechnet, BaselArea and Life Sciences Zurich. www.swisslifesciences.comwww.swisslifesciences.com Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy. www.venturevaluation.comwww.venturevaluation.com
3
Overview of the Swiss Life-science Industry 2014 Statistics Total Biotech Companies346 Medtech companies258 Pharma companies46 Investor companies36 Public / Non-Profit Organizations / Medical Facilities209 Other Life sciences companies927 Percentage of Publicly Owned Companies3% Venture Capital Raised (2013)USD 401m Venture Capital Raised (2012)USD 249m Number of Technologies163 Licensing Opportunities128
4
Number of Employees
5
Company Ownership
6
Overview of the Swiss Biotechnology Industry 2013 Statistics2014 Statistics 345Total Biotech Companies346 102Biotech - Therapeutics101 178Biotech - R&D Services172 65Biotech - Other73 89%Percentage of SME's94% 4%Percentage of Publicly Owned Companies4% USD 153m (2012)Financing/Capital RaisedUSD 325m (2013) 171Licensing Opportunities100
7
Company Foundation Timeline
8
Key Activities of Biotechnology Companies
9
Biotech products - Breakdown by Indication
10
Products in the Pipeline – Three-year Trend
11
Venture Financing in Switzerland – Half-yearly Data
12
Major Biotech Financing Rounds (H2 2013 – H1 2014) CompanySectorUSD M NovImmune SA Biotech – Therapeutics & Diagnostics 67 Covagen AG Biotech – Therapeutics & Diagnostics 47 Biocartis SA Biotechnology - R&D Services 40.5 ADC Therapeutics, Inc Biotech – Therapeutics & Diagnostics 40 Anokion SABiotechnology - R&D Services37.2
13
About Biotechgate Biotechgate contains over 30’000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data. To register for free or learn more about the different subscription options, please visit www.biotechgate.com. www.biotechgate.com
14
Terms of Use The “Swiss Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at www.biotechgate.com. The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof. The use of the figures and graphs provided in this report is free of charge for any presentations as long as www.biotechgate.com is clearly cited as the source. For all other uses please contact us for terms and conditions. Biotechgate c/o Venture Valuation VV AG Kasernenstrasse 11+41 (43) 321 86 60 8004 Zurichinfo@venturevaluation.com Switzerlandwww.venturevaluation.com
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.